To overcome this limitation, amplification-free targeted sequencing has been first described in a Fuchs’ endothelial corneal dystrophy-associated Transcription Factor 4 (TCF4) CTG triplet repeat [49]. The gene discussed is TCF4; the disease is Fuchs endothelial corneal dystrophy.